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ABSTRACT 
     Total healthcare expenditures and expenditures as a percentage of GDP have been 
substantially higher in the U.S. than in Canada between 1975 – 2008. Hospitalcare, 
physician and clinical services, and drug prescription expenditures have been the 
principal components contributing to growth in healthcare expenditures in the U.S. 
compared to Canada. This study reviews the literature on increasing healthcare costs 
and establishes some comparative and descriptive analysis for high healthcare costs in 
the two countries during this time period. The study also analyses and compares the 
growth of healthcare costs. 
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Introduction 
A healthy population is believed to be a driver and a catalyst for achieving 
economic growth. The health of any nation is of paramount importance and has a 
positive correlation with economic growth Sachs et al. (2001). Health means the state of 
being fit and mentally balanced to react to changes in the environment. Generally 
speaking, it is a state of wellness and completeness of a person. Alleyne et al. (2002) 
revealed that health consistently ranked the number one thing men and women desired 
in life.  
Variations in healthcare expenditures among countries are substantial regardless 
of how they are measured. Across the globe, many countries have continuously 
increased healthcare budgets. Leslie Norwalk, former acting administrator for Center 
for Medicare & Medicaid Services (CMS) in a press release by CNNMoney in 2011 stated 
that “healthcare spending will double by 2020, and the government will pay 50% of that 
-- this is troubling”. Auerbach an economist at RAND Corporation in a press release in 
2011 argues that “unless we reverse the trend, Americans increasingly will notice that 
health costs compromise their other spending options. 
Research has also shown that a healthy population is a necessary requirement for 
economic growth. This  trend was shown in the work of Fogel (1991, 1997, 2000), whose 
ground - breaking studies have explained the relationship between body size and food 
supply, and have shown the latter to be critical to long – term labor productivity.  
 Szick et al. (1999) of the Institute for Clinical and Evaluative Sciences Ontario Canada 
have found that four decades ago, Canada and U.S. operated similar healthcare systems, 
but the situation has changed drastically since 1984 when Canada passed the Canadian 
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full single payer system (Canadian Health Act of 1984) revising the Medical Care Act of 
1966 which prohibits user fees and extra fees from doctors. They stated that several 
studies have compared healthcare cost and outcomes. However, none of these studies 
provided conclusive evidence why there is a difference between U.S. and Canada 
healthcare system. 
The relationship between health and economic growth has also been established 
by studies on a more modest scale considering groups of children who can be separated 
according to the calorie intakes during their first 3 years of life. It is clear from these 
studies that those with higher calorie intakes generally attain higher incomes 30 years 
later in life, and are therefore presumably more economically productive (Hernandez, 
Fuentes, and Pascual, 2001). 
These results could be the rationale behind spending on health. Healthy countries 
with educated men and women have the potential to grow economically, especially in a 
favorable policy environment. Clements et al. (2012) of the International Monetary 
Fund (IMF) and  Ginsburg (2006) indicates that healthcare costs have increased in 
developing and developed countries for more than two decades, and this is causing 
serious debates and reevaluation of the benefits and performance of healthcare 
spending. 
According to the Henry J. Kaiser Family Foundation (2009) healthcare costs 
around the world are steadily growing faster than general economic growth and a 
majority of countries have seen healthcare spending as a percentage of their gross 
domestic product (GDP) increase over time. The Organization for Economic Co-operation 
and Development (OECD) health data (2006) shows that healthcare spending is 
increasing at a higher rate than incomes in developing and developed countries. This has 
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raised serious questions about how countries will pay for their future healthcare needs. 
Growth in healthcare expenditures has been particularly high in the U.S. The OECD 
health data (2006) show that the U.S. spends much more per capita on healthcare and 
also has the largest spending growth rates in the world. The percentage of wealth the U.S. 
spends on healthcare services is fast becoming worrisome to economists, its citizens and 
health practitioners in the U.S., far surpassing other developed countries like Canada. 
This paper further stated that a major challenge is that U.S. does not have better 
healthcare records in terms of life expectancy, number of physicians per capita and 
number of nurses per 1,000 population when compared to other developed countries like 
Canada despite huge expenditure in healthcare services. 
Over the years, the healthcare systems of U.S. and Canada have been studied and 
compared by several analysts with further work ongoing. The most difficult question left 
unanswered is whether the expected healthcare outcomes of patients in these two 
countries would be the same if identical techniques and methods are applied in both 
countries in treatment of patients. Szick, et al. (1999) stressed that little research has 
been directed at this question. This study seeks to improve our understanding of the 
differences in healthcare expenditure growth in the U.S. and Canada. The study covers 
the period between 1975 through 2008.  
Literature Review  
The literature review is organized in two sections. First, I reviewed the literature 
focusing on the connection between economic growth and health in general. Secondly, I 
report on findings in the literature specific to the growth of healthcare expenditures the 
U.S. and Canada.  
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Health and Economic Growth 
The connection between health and economic growth has long been established 
in the literature, for instance Bloom et al. (2005) stated that health is an important form 
of human capital and it can enhance workers’ productivity by increasing their physical 
capacities, such as strength and endurance.  The importance of health and investment in 
healthcare are major components of the development goals pursued by developing and 
developed countries around the globe. The increasing attention healthcare delivery is 
receiving worldwide has further emphasized the importance of health and healthcare 
expenditure on economic growth. 
Higher expenditure on health alone cannot meet a given nation’s development 
goals. However, in conjunction with other social investments, it can drive economic 
growth. A healthy person is full of life and energy and a healthy society tends to be 
energetic and actively involved in productive ventures. The work of Baldacci (2004) 
elucidates the importance of health expenditures. His  panel data analysis based on 
about one hundred and twenty developing countries from 1975-2000 indicated that 
spending on health affects growth within that same period, while lagged health 
expenditures appear to have no noticeable  effect on growth.  
Spending in healthcare services can lead to improvements in health. There are 
several studies showing that improvements in health can positively influence economic 
growth through its effects on fertility, labor productivity, and the quality of human 
capital.  For example, Sachs (2001) and Bloom et al. (2005) find positive correlations 
between health and economic growth.  
However, there are some disagreements and divergent views concerning the 
effects of increased healthcare spending. For instance, Baldacci et al. (2003) and Gupta 
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et al. (2002b) find that social spending is an important determinant of education and 
health outcomes. This work, based on cross-sectional data for developing countries, 
reveals that expenditures on education have a greater effect on social indicators than 
health expenditures.  
Despite these differences, most studies find a positive relationship between 
health and economic growth. Levine and Renelt (1992) and Sala-I-Martin (1997a, 
1997b) find  that out of more than 32,000 regressions involving permutations of over 60 
variables, initial life expectancy is a positive and significant predictor of economic 
growth in more than 96 percent of the specifications. This indicates that good health at 
early age and beyond is one of the most robust predictors of subsequent economic 
growth and could justify the increased levels of spending in healthcare by developing 
countries like India and Nigeria and developed countries like U.S. and Canada. 
This is corroborated by Sachs (2001), who finds that “extending the coverage of 
crucial health services to the world’s poor could save millions of lives each year, reduce 
poverty, spur economic development, and promote global security. According to this 
view, achieving better healthcare may be able to accomplish what development 
practitioners, NGOs, economists, foreign aid providers, and diplomacy have failed to 
achieve. Several researchers who have found a significant correlation from health to 
growth (e.g., Bloom and Canning, 2003) have used these types of findings to argue for 
large increases in governmental spending on health care. 
Health and education have also been found to be influential factors in human 
capital formation. Advanced levels of education attainment create an enabling 
environment for awareness among the public and the ability of families to solve their 
health problems.  For example, Barro (1996b) argues that improved health can reduce 
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the depreciation of education capital, and thus increase the favorable effect of education 
on growth. A more recent study by Gyimah- Brempong and Wilson (2004) finds a 
positive and robust link between investment in health and growth in both sub-Saharan 
African and OECD countries. 
Growth in Healthcare Spending 
Empirical studies suggest the existence of a correlation between the growth of an 
economy and growth in governmental social and economic spending.  For example, 
Devarajan, et al., (1996) show that moderated and prudent expenditure can lead to 
development but could be unproductive if it becomes excessive especially in developing 
countries. The Milken Institute report (2007), suggests that as a country’s health 
improves (as calculated by several factors, such as improvement in Medicare and health 
research) we should expect to see an improvement in labor productivity and output per 
worker, as well as an increase in economic growth.  
Improvement in health may lead to income growth, but this does not necessarily 
imply that developing and developed nations should allocate a greater percentage of 
their budget on healthcare. As Bloom and Canning (2003: 313,) state, “The key issue is 
not that spending on health would be good, it is whether spending on health is better 
than other uses of the limited funds available in developing countries.”  
As a nation grows in size and population, it is expected that other traditional functions 
of the state would rise in importance, and there would be a natural force exerting 
pressure on public expenditure thereby increasing the cost of governance and 
administration of a state and country in social and economic activities. For instance, 
expenditures on education and infrastructural development could reduce as a result of 
increased expenditure in healthcare services.   For example, Cincotta and Engelman 
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(1997) emphasized that decline in fertility (population reduction more or less fueled 
economic growth during the early 1990s in countries like Taiwan, South Korea, 
Thailand, Hong Kong, Malaysia and Indonesia. 
Developed and developing nations have over the years shifted attention to 
investments in health-related activities because of its social benefits in both in the short 
run and long run. OECD health data (2006) has shown that this universal tendency of 
increased spending on healthcare has become a trend among nations of the world. The 
questions that need urgent answers are (1) for how long will this trend continue? (2) Are 
the social benefits derived from these actions commensurate with the expenditures? and 
(3) what are the best ways of measuring the costs and benefits of such a trend? 
Roehrig et al. (2012) find that control in healthcare expenditure started about 2.5 years 
before the recession engulfed the economy in 2008, therefore the economy cannot be 
held accountable for the slowdown in the curve. He further stated that economists and 
policy makers often compare the growth of health care spending to that of the overall 
economy, as measured by the gross domestic product (GDP), but this comparison can 
give a false sense of “excess” healthcare spending growth during economic recessions 
and recoveries. Woolhandler (2003) finds that the difference between U.S. and 
Canadian expenditure on healthcare administration has grown steadily over the years, 
and that large sums could be saved in the U.S. if healthcare administration costs are cut  
by adopting the Canada’s single payer healthcare system. Redelmeier (1993) finds that 
after all adjustments are made for population size and the exchange rate between the 
U.S. and Canada, the reasons for the high healthcare expenditure in the U.S. is 
attributable to higher administrative costs, hospital costs, physician services, and 
prescription drugs. 
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Szick et al. (1999) find that U.S. and Canada operated the same healthcare 
systems about four decades ago before Canada restructured its system in the 1984.  
According to the Kaiser family foundation (2009) the portion of GDP earmarked for 
healthcare spending in the U.S. grew from 9% of GDP in 1980 to 16% of GDP in 2008. 
This percentage increase in health spending as a portion of GDP is high when compared 
with other developing and developed countries. Also, OECD health data (2004) shows 
that the U.S. spent US$6,714 per-capita on health care expenses, while Canada spent 
US$3,678. In the same year, the U.S. spent 15.3% of GDP on healthcare while Canada 
spent 10.0%.  
OECD health data (2004) and Mckinsey Global Institute (2008) report shows 
that U.S. healthcare expenditure as a proportion of GDP has been unstable over the 
years compared to Canada’s. Schabloski (2008) finds that the main difference between 
the U.S. and Canadian healthcare systems is that while the U.S. effectively runs a private 
managed healthcare system, Canada adopts a comprehensive, publicly funded 
healthcare system. The U.S. is the only country in the developed world, and one of only 
two OECD countries, that does not already have a fundamentally public- tax-supported 
healthcare system.  
The report on healthcare by Canada Institute for Health Information (CIHI) 2010 
and the Commonwealth Fund (2011) reveal that Canada’s healthcare system provides 
universal coverage for hospital services, physicians and prescription drugs for its 
citizens and permanent residents. The Canadian healthcare regulation ensures that all 
insured persons be fully insured, without co-payments and other associated medical 
fees. The trademark of Canada’s universal healthcare system includes the nonexistence 
of copayments and the government directly provides and funds a wide range of 
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preventive services through Public Health Agency of Canada. The Canadian system is 
often advocated as an alternative that the U.S. might emulate. The U.S. health system 
requires that some of its citizens’ pay for their healthcare needs, and the Kaiser 
Commission on Medicaid and the Uninsured (2006) finds that about 15%, or 40 million 
American residents, were reported to be uninsured at any point in time in 2004.  
Another difference between the two systems is in their administration. The report 
on the state of the healthcare in Canada (2002) by Canada health act revealed that in 
Canada, the government is wholly committed to provide funds and public health 
services  to its district governments for healthcare expenditures, provided they accept 
the Canadian healthcare regulations, which clearly and explicitly disallow billing 
patients’ treatments that are covered by Medicare. The authors also find that Canadian 
hospitals are managed by private boards/and or regional health authorities that are 
separated from the government. 
In the U.S., the federal government funds Medicare, Medicaid, and state health 
insurance for children. Those types of people covered include qualified old citizens, the 
poor, persons with disabilities, and children.   The Kaiser Commission on Medicaid and 
the Uninsured (2006) find that a majority of residents in the U.S. have access to 
healthcare through their employers, while the unemployed or individuals whose 
employers do not have coverage pay from their pockets.  However, federal and state 
agencies are actively involved in healthcare spending irrespective of private 
involvement. The U.S. Department of Health and Human Services, Centers for Disease 
Control and Prevention (2010), found that federal and state agencies pay about 47% of 
the $2.2 trillion spent nationally on medical care in 2004.  
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Schabloski (2008) and International Profiles of Healthcare Systems (2010) find 
that Canadian system has been 60–74% publicly funded, but these services are 
administered by private providers. Canada’s healthcare system does not cover certain 
services. Comparing the merits of private versus public healthcare funding, one is 
tempted to conclude that privately funded healthcare is not attractive. OECD data (2011) 
shows that the U.S. has the most expensive healthcare system in the world. A study by 
Harvard Medical School researchers Steffie Woolhandler and David Himmelstin in July 
2006 and OECD health data 2011, reveal that irrespective of the outstanding technology 
that the U.S. possesses; the overall health of the U.S. population is actually worse than 
in most developed countries, and the mortality rates are relatively high in the U.S. 
However, these ‘aggregate’ measures are not necessarily accurate, as many other 
reasons outside healthcare affect mortality. 
The U.S. has continued with the same healthcare system decades after Canada 
restructured its system. This difference in healthcare in the U.S. and Canadian systems 
reveals that private funding may lead to poorer public health. Squires (2012) stated that 
in all industrialized countries, U.S. is the only country without universal insurance-
based or tax financed systems. Rodin and Ferranti (2012) also revealed that among 25 
wealthiest Nations, only the U.S. does not have some form of universal coverage.  They 
further stated that several middle-income countries, including Brazil, Mexico, and 
Thailand have universal healthcare system while Lower-income nations, such as the 
Philippines, Vietnam, India, China, South Africa, Rwanda, and Ghana are working 
towards adopting universal healthcare system. Kelly (2009) projects that the U.S. would 
be able to save over $160 billion every year in administration expenses if it adopts the 
Canadian system of healthcare.  
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Docteur et al. (2009) finds that death rates are high in the U.S. compared to 
OECD countries. Devereaux et al. (2004) finds that the high death rates have been 
linked to unprofessional and unethical practices of for-profit hospitals that need to 
maximize profit for stakeholders and compensate hospital managers. They find that 
hospital administrators tend to employ less-skilled practitioners to lessen costs. This 
study therefore suggests that many patients will die if profit motives are the reasons for 
establishing hospitals. 
The switch by Canada to a universal system is believed by some to be the main 
reason why Canadians are generally healthier regardless of income when compared to 
U.S. residents.  Also, Squires (2012) finds that one potential explanation for the high 
level of U.S. health care spending is the aging population. As the baby boom generation 
enters retirement age there is correspondingly greater healthcare needs. In addition, an 
analysis by Anderson (2011) shows that U.S. prices for drugs, brand-name drugs, and 
procedures are highest in the 30 most-commonly prescribed drug categories compared 
to Canada.  
Comparative Analysis 
As shown in Figures 1 and 2, using the data collected from CIHI and NHEA the 
gap between the spending on healthcare in total and as a portion of GDP in the U.S. and 
Canada has grown steadily since 1975. The Canada Institute for Health Information 
CIHI (2012) report shows that the pace of growth is slowing however. The three major 
components of total healthcare expenditure in the U.S. and Canada are hospitalcare, 
physician and clinical services, and prescription drugs. However, public health, other 
professional services, other health institutions and other health spending make up the 
other categories of healthcare expenditure that are less significant compared to the three 
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major components.  The CIHI (2012) report indicates that drug spending growth rates 
have trended downward over the last 10 years in Canada. This decline is likely due to 
fewer drugs coming on the market in the last decade, many blockbuster drugs patent, 
and CIHI (2010) data shows that in 2008 the total healthcare expenditure in the U.S. is 
$2,339 billion and in Canada it is $172 billion while Figure 2 shows that the proportion 
of the U.S. healthcare expenditure as percentage of   GDP in the same year was 17.8% 
while in Canada it was 10.7%. 
Figures 3 and 4 show changes in different healthcare expenditure components 
per unit of GDP in the U.S. and Canada from 1975 - 2008.  According to the Henry J. 
Kaiser Family Foundation (2010), the U.S spent $234.1 billion in 2008 on prescription 
drugs, which is about six times the amount ($40.3) billion spent in  
From Figure 3 and 4, we see that the three different healthcare expenditure 
components in Canada and the U.S. have followed almost the same pattern since 1975, 
with only slight variations. This is validated by CIHI (2012) report which shows that 
reimbursement paid to health care providers has been one of the major cost drivers of 
hospital and physician spending in Canada. The report further stated that increases in 
compensation due to higher demand as well as to growth in the number of hospital 
workers and physicians may have added to higher spending during the last decade. In 
Canada, the drug prescription expenditure per GDP was 0.60% in 1975 and 1980. 
However, by 2007 it has risen to 1.7%. 
Figures 5, 6 and 7 compare the hospitalcare, physician services, and drug 
prescription services expenditure per GDP in the U.S. and Canada. From Figure 5, we see 
that the hospitalcare spending per GDP in 1975 and 1980 was higher in the U.S. than in 
Canada. It was 3.2% and 3.6% in 1975 and 1980 respectively in the U.S., while in Canada 
13 
 
it is 2.9% in 1975 and 1980.  However, the gap was high in 2008; it is 5.5% in the U.S. 
while it is 3.1% in Canada. From Figure 6, we see that the physician services expenditure 
per GDP was also higher in the U.S. compared to Canada.  It was 0.6% in Canada in 1975 
and 1.5% in the U.S. and in 2008 it was 3.8% in the U.S. while in Canada it is 1.4%. From 
Figure 7, the drug prescription expenditure per GDP has been higher in Canada 
compared to the U.S. since 1975.  It was 0.6% in 1975, 1.0% in 1990 and 1.4% in 2000 in 
Canada while in the U.S. it was 0.5% 1975, 0.7% in 1990 and 1.2% in 2000.  However, 
between 2008 and 2012 the drug prescription expenditure in the U.S. was higher 
compared to Canada after several years. It was 1.8% in 2008 in the U.S. and 1.7% in 
Canada. According to the Henry J. Kaiser Family Foundation (2010), the rate of increase 
in spending on drug prescription since year 2000 with the exception of year 2006 in the 
U.S. was as a result of increased use of prescription drugs which was due to a number of 
factors including the implementation of Medicare Part D, increased use of specialty 
drugs, lower refunds from drug manufacturers and changes in the mix of drugs (both 
brand versus generic). Medicare Part D is also called the Medicare prescription drug 
benefit, a federal program to subsidize the costs of prescription drugs for Medicare 
beneficiaries in the United States. According to CIHI (2012) report and Jonathan (2005), 
the steady decrease in drug prescription expenditure in Canada are as a result of 
government strict regulations on drug utilizations and price controls that limit the 
increase in prescription drug prices while in the U.S. the steady increase in drug 
prescription expenditure could be attributed to the non-existent of enforced government 
regulations on drug and controls to limit the increase in prescription drug prices. 
 
 
14 
 
Model Specification 
The model used is a simple ordinary least squares semi-log approach to estimate 
growth rates for spending on hospital care, physician and clinical services, and 
prescription drugs in both the U.S. and Canada (Gujarati and Porter, 2010).This 
approach was chosen because it gives better approximation in calculating growth rate, it 
gives closer connection between the process of linear growth and exponential growth. 
The advantages of semi-log specification include; easy interpretation of coefficients and 
it mitigates the impact of nonlinear relationships.  
Let tY  represent health care spending in year t, Y0 represents the value of 
healthcare spending in time 0 and r is the rate of growth of Y over time. Starting with 
the simple growth formula 
  0 1
t
tY Y r  ……………………… (1) 
Transforming the model by taking the natural log of (1), we have  
 0ln ln ln(1 )tY Y t r   …….…… (2) 
Now, letting 0 1lnY B  and 2ln(1 )r B  , we use the simple regression model 
 1 2ln t tY B B t     …………….. (3) 
Also let    vary whether or not there was a recession the previous year. 
   =      +    Recession 
ln    =   +        +     Recession 
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Growth Rate Estimates 
To estimate the growth rate in healthcare spending, we transform (1). The estimates of 
the growth rate (r) can be derived from 2ln(1 )r B  .Transforming the expression by 
exponentiation we have  
                                           r =       – 1 ……………………….. (4) 
The essence of estimating it using the data collected is to compare the results with the  
analysis in literature review and see if they are in agreement. 
Roehrig et al. (2012) suggests that healthcare spending may vary across the 
business cycle. We therefore allow 2B  to vary according to whether or not there was a 
recession in year t. To allow for the possibility of lagged effects, we also estimate 
specifications where 2B  is allowed to vary according to whether or not there was a 
recession the previous year. The reason for varying 2B  is to ascertain if recession has 
effect on healthcare spending or not. 
Results  
Our regression results are reported in Tables 1 and 2. The growth rates implied by 
these estimates are reported in Tables 3 and 4. We find that the average growth rate for 
total spending on healthcare services in the United States is 8.70%. For Canada, our 
estimate is 7.70% etc. The main reason for estimating the growth rate using the data 
collected from CIHI and NHEA is to compare the results of studies in the literature 
review.  The growth rate estimate in table 3 and 4 were gotten using equation 4. 
The findings from this study and analysis in the literature review definitely 
revealed that U.S. spends more than Canada on healthcare services. The growth rate is 
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higher in the overall total healthcare in the U.S. compared to Canada. Also, the growth 
rate is higher in the U.S. compared to Canada in hospitalcare services, physician and 
clinical services and prescription drug. The graphs showed that the growth rate in 
healthcare expenditure in both countries is positive each year between 1975 and 2008. 
The regression analyses only show that the growth rate is not statistically different during 
or after recession year in either country. The results revealed that recession or economic 
crisis might have contributed less to the fall in healthcare cost. Nevertheless, the 
healthcare costs are extremely high in both countries. 
Summary 
Healthcare Costs have been both high and growing steadily in the U.S. and 
Canada during the years 1975 to 2008. The findings from our studies of healthcare costs 
in the U.S. and Canada provide a convincing answer to the question of how the United 
States compares to Canada in terms of the spending in healthcare. This is simply 
because the growth rate estimate of spending in total healthcare, hospital care, 
physician and clinical services and drug prescription in the U.S. is higher compared to 
Canada. 
There is a big gap between the U.S. and Canadian spending on healthcare. Huge 
sum of money could be saved by the U.S. if cost of administration, abuse, fraud and 
prescription drugs is reduced by implementing similar or modified system as found in 
Canada. 
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Conclusions 
Changes in government policy, fraud and abuse, medical technology, aging 
population, increased  usage of prescription drugs, spending in hospitalcare services, 
physician and clinical services, administrative cost and population growth are some of 
the reasons why healthcare cost have risen so high in U.S. and Canada.  Growing 
healthcare costs have created worries that continued growth could negatively affect the 
economy of U.S. and Canada, as well could create problems for overall spending in the 
economy such as expenditure in education and infrastructural developments. The 
literature review as shown by the work of Baldacci (2004) and Bloom and Canning 
(2003) emphasized the connection between the growth of healthcare cost and rate of 
economic development. 
I found that recession and absence of recession does not have a statistical 
significant effect on healthcare spending. This study attempts to compare U.S. and 
Canada health expenditures.  Progresses in medicine make people to spend more on 
healthcare in order to prolong life. Modifications in government policy and other 
endogenous variables increase health expenditures.  This study has provided the 
descriptive analysis of how modifications in government programs such as Medicare 
and Medicaid could account for increased spending on health in the U.S.  compared to 
Canada.  
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Source: CIHI and NHEA 2010 
Source: CIHI and NHEA 2010 
  
0.0%
0.2%
0.4%
0.6%
0.8%
1.0%
1.2%
1.4%
1.6%
1.8%
2.0%
1970 1980 1990 2000 2010
Year 
     Figure 7: Prescription Drug  Expenditure Per GDP 
CANADA
UNITED
STATES
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
7.0%
8.0%
1970 1980 1990 2000 2010
Year 
 Figure 8: Other Expenditure Per GDP 
CANADA
UNITED
STATES
24 
 
Table 1: United States 
VARIABLES Total Spending 
 
Hospital Spending 
 
Physician and Clinical Spending 
 
Prescription Drug Spending 
  
 
    
 
      
 
      
 
      
Year 0.0841*** 0.0842*** 0.0840*** 
 
0.0740*** 0.0740*** 0.0739*** 
 
0.0889*** 0.0891*** 0.0888*** 
 
0.1096*** 0.1098*** 0.1096*** 
 
(41.00) (39.59) (41.371) 
 
(32.38) (31.19) (32.70) 
 
(32.25) (31.17) (32.25) 
 
(98.40) (96.01) (99.53) 
…*Recession -- -0.0007 -- 
 
-- -0.000 -- 
 
-- -0.0011 -- 
 
-- -0.0012 ---- 
  
(-0.26) 
 
 
 
(-0.010) 
 
 
 
(-0.30) 
 
 
 
(-0.83) 
 …*Recession 
Last Year -- -- 0.0040 
 
-- -- 0.0046 
 
-- -- 0.0044 
 
-- -- 0.0023 
   
(1.27) 
 
  
(1.30) 
 
  
(1.02) 
 
  
(1.32) 
Constant 5.067*** 5.068*** 5.058*** 
 
4.190*** 4.190*** 4.179*** 
 
3.405*** 3.406*** 3.395*** 
 
1.880*** 1.881*** 1.875*** 
 
(123.17) (121.33) (122.02) 
 
(91.41) (89.93) (90.58) 
 
(61.58) (60.68) (60.39) 
 
(84.18) (83.77) (83.49) 
Observations 34 34 34 
 
34 34 34 
 
34 34 34 
 
34 34 34 
R-squared 0.981 0.981 0.982 
 
0.970 0.970 0.972 
 
0.970 0.970 0.971 
 
0.997 0.997 0.997 
 
Table 2: Canada 
VARIABLES Total Spending 
 
Hospital Spending 
 
Physician and Clinical Spending 
 
Prescription Drug Spending 
                                
Year 0.0743*** 0.0742*** 0.0743*** 
 
0.0591*** 0.0588*** 0.0590*** 
 
0.0729*** 0.0726*** 0.0728*** 
 
0.1002*** 0.1004*** 0.1002*** 
 
(29.41) (28.31) (29.79) 
 
(19.24) (18.50) (19.32) 
 
(17.86) (17.16) (17.89) 
 
(42.68) (41.23) (43.27) 
…*Recession -- 0.0011 -- 
 
-- 0.0016 -- 
 
-- 0.0013 -- 
 
-- -0.0009 -- 
  
(0.33) 
   
(0.40) 
   
(0.26) 
   
(-0.29) 
 …*Recession 
Last Year -- -- 0.0053 
 
-- -- 0.0055 
 
-- -- 0.0070 
 
-- -- 0.0050 
   
(1.37) 
   
(1.16) 
   
(1.10) 
   
(1.39) 
Constant 2.7196*** 2.7191*** 2.7068*** 
 
1.9572*** 1.9565*** 1.9439*** 
 
0.7734*** 0.7728*** 0.7566*** 
 
0.1297*** 0.1301** 0.1176** 
 
(53.63) (52.84) (53.19) 
 
(31.78) (31.34) (31.20) 
 
(9.44) (9.29) (9.11) 
 
(2.75) (2.72) (2.49) 
Observations 34 34 34 
 
34 34 34 
 
34 34 34 
 
34 34 34 
R-squared 0.964 0.964 0.966   0.920 0.921 0.924   0.909 0.909 0.912   0.983 0.983 0.984 
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Table 3: Growth Rate Estimates  
 
Total Spending Hospital Spending 
Physician and  
Clinical Services 
Prescription  
Drug Spending 
United States 8.784 7.680 9.318 11.605 
Canada 7.702 6.056 7.530 10.561 
 
